Geographic indicatiors in the world and in Turkey and the case of Adapazari Islama Köfte
2013
0 views
0 downloads
Advisor: Yrd. Doç. Ahu Erdoğdu
Abstract (EN)
The view that local product preference is a stance against globalization and the approach of preserving traditional are gaining strength gradually. Local culinary culture and local product has a huge role to strengthen the local economy, also preserve the traditional local product reservoir that is distilled from social life and tradition hundreds of years. This study aims to analyze the local products within the context of Geographical Indicators (GI) and addresses the issues of registration, usage and inspection of geographic indicators, conditions and stages of their registration, their protection according to various national and international regulations and through trademarks. Within the scope of this research that is designed as a descriptive and exploratory study, alternative ways of certification for the GIs are investigated in relation to unfair competition, branding law and administrative arrangements .
Author
Eser Atay
Institution
Yeditepe University
Bütünleşik Pazarlama İletişimi Yönetimi Bilim Dalı
How to Cite
Eser Atay (Master Thesis). Geographic indicatiors in the world and in Turkey and the case of Adapazari Islama Köfte, 2013, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)